Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma

NCT02586506 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02586506
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02586506 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of the Ease of Use and Correct Use of Placebo ELLIPTA Dry Powder Inhaler in Subjects With Asthma
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2015
Completion date
February 4, 2016
Enrollment
259 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

asthma